Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2025-2031

August 2025 | 92 pages | ID: G675ECA4C413EN
LP Information

Abstracts

According to this study, the global Tuberculosis (TB) Diagnostics market size will reach US$ 4099 million by 2031.

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X-ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.

Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

LPI (LP Information)' newest research report, the “Tuberculosis (TB) Diagnostics Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Diagnostics sales for 2025 through 2031. With Tuberculosis (TB) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tuberculosis (TB) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Culture-Based Diagnostics
• Sputum Smear Microscopy
• Rapid Molecular Diagnostics
• Others

Segmentation by Application:

• Diagnostic Laboratories
• Hospitals

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Danaher
• Roche
• Thermo Fisher Scientific
• BD
• Abbott
• Hologic
• Qiagen
• BioMerieux
• Hain Lifescience
• Oxford Immunotec

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tuberculosis (TB) Diagnostics Market Size (2020-2031)
  2.1.2 Tuberculosis (TB) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Tuberculosis (TB) Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Tuberculosis (TB) Diagnostics Segment by Type
  2.2.1 Culture-Based Diagnostics
  2.2.2 Sputum Smear Microscopy
  2.2.3 Rapid Molecular Diagnostics
  2.2.4 Others
2.3 Tuberculosis (TB) Diagnostics Market Size by Type
  2.3.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Tuberculosis (TB) Diagnostics Segment by Application
  2.4.1 Diagnostic Laboratories
  2.4.2 Hospitals
2.5 Tuberculosis (TB) Diagnostics Market Size by Application
  2.5.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)

3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Tuberculosis (TB) Diagnostics Market Size Market Share by Player
  3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TUBERCULOSIS (TB) DIAGNOSTICS BY REGION

4.1 Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
4.4 APAC Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
4.5 Europe Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
5.2 Americas Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
5.3 Americas Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
6.2 APAC Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.3 APAC Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
7.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tuberculosis (TB) Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET FORECAST

10.1 Global Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas Tuberculosis (TB) Diagnostics Forecast
  10.1.3 APAC Tuberculosis (TB) Diagnostics Forecast
  10.1.4 Europe Tuberculosis (TB) Diagnostics Forecast
  10.1.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast
10.2 Americas Tuberculosis (TB) Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market Tuberculosis (TB) Diagnostics Forecast
  10.2.2 Canada Market Tuberculosis (TB) Diagnostics Forecast
  10.2.3 Mexico Market Tuberculosis (TB) Diagnostics Forecast
  10.2.4 Brazil Market Tuberculosis (TB) Diagnostics Forecast
10.3 APAC Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
  10.3.1 China Tuberculosis (TB) Diagnostics Market Forecast
  10.3.2 Japan Market Tuberculosis (TB) Diagnostics Forecast
  10.3.3 Korea Market Tuberculosis (TB) Diagnostics Forecast
  10.3.4 Southeast Asia Market Tuberculosis (TB) Diagnostics Forecast
  10.3.5 India Market Tuberculosis (TB) Diagnostics Forecast
  10.3.6 Australia Market Tuberculosis (TB) Diagnostics Forecast
10.4 Europe Tuberculosis (TB) Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market Tuberculosis (TB) Diagnostics Forecast
  10.4.2 France Market Tuberculosis (TB) Diagnostics Forecast
  10.4.3 UK Market Tuberculosis (TB) Diagnostics Forecast
  10.4.4 Italy Market Tuberculosis (TB) Diagnostics Forecast
  10.4.5 Russia Market Tuberculosis (TB) Diagnostics Forecast
10.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Tuberculosis (TB) Diagnostics Forecast
  10.5.2 South Africa Market Tuberculosis (TB) Diagnostics Forecast
  10.5.3 Israel Market Tuberculosis (TB) Diagnostics Forecast
  10.5.4 Turkey Market Tuberculosis (TB) Diagnostics Forecast
10.6 Global Tuberculosis (TB) Diagnostics Forecast by Type (2026-2031)
10.7 Global Tuberculosis (TB) Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Tuberculosis (TB) Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Danaher
  11.1.1 Danaher Company Information
  11.1.2 Danaher Tuberculosis (TB) Diagnostics Product Offered
  11.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Danaher Main Business Overview
  11.1.5 Danaher Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Tuberculosis (TB) Diagnostics Product Offered
  11.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
  11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 BD
  11.4.1 BD Company Information
  11.4.2 BD Tuberculosis (TB) Diagnostics Product Offered
  11.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 BD Main Business Overview
  11.4.5 BD Latest Developments
11.5 Abbott
  11.5.1 Abbott Company Information
  11.5.2 Abbott Tuberculosis (TB) Diagnostics Product Offered
  11.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Abbott Main Business Overview
  11.5.5 Abbott Latest Developments
11.6 Hologic
  11.6.1 Hologic Company Information
  11.6.2 Hologic Tuberculosis (TB) Diagnostics Product Offered
  11.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Hologic Main Business Overview
  11.6.5 Hologic Latest Developments
11.7 Qiagen
  11.7.1 Qiagen Company Information
  11.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Offered
  11.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Qiagen Main Business Overview
  11.7.5 Qiagen Latest Developments
11.8 BioMerieux
  11.8.1 BioMerieux Company Information
  11.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Offered
  11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 BioMerieux Main Business Overview
  11.8.5 BioMerieux Latest Developments
11.9 Hain Lifescience
  11.9.1 Hain Lifescience Company Information
  11.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
  11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Hain Lifescience Main Business Overview
  11.9.5 Hain Lifescience Latest Developments
11.10 Oxford Immunotec
  11.10.1 Oxford Immunotec Company Information
  11.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
  11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Oxford Immunotec Main Business Overview
  11.10.5 Oxford Immunotec Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tuberculosis (TB) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Tuberculosis (TB) Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Culture-Based Diagnostics
Table 4. Major Players of Sputum Smear Microscopy
Table 5. Major Players of Rapid Molecular Diagnostics
Table 6. Major Players of Others
Table 7. Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
Table 10. Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)
Table 13. Global Tuberculosis (TB) Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player (2020-2025)
Table 15. Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
Table 16. Tuberculosis (TB) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2020-2025)
Table 21. Global Tuberculosis (TB) Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Country (2020-2025)
Table 25. Americas Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
Table 27. Americas Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)
Table 29. APAC Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2020-2025)
Table 31. APAC Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Country (2020-2025)
Table 35. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Tuberculosis (TB) Diagnostics
Table 41. Key Market Challenges & Risks of Tuberculosis (TB) Diagnostics
Table 42. Key Industry Trends of Tuberculosis (TB) Diagnostics
Table 43. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Danaher Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 48. Danaher Tuberculosis (TB) Diagnostics Product Offered
Table 49. Danaher Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Danaher Main Business
Table 51. Danaher Latest Developments
Table 52. Roche Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 53. Roche Tuberculosis (TB) Diagnostics Product Offered
Table 54. Roche Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
Table 59. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. BD Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 63. BD Tuberculosis (TB) Diagnostics Product Offered
Table 64. BD Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. BD Main Business
Table 66. BD Latest Developments
Table 67. Abbott Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 68. Abbott Tuberculosis (TB) Diagnostics Product Offered
Table 69. Abbott Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Abbott Main Business
Table 71. Abbott Latest Developments
Table 72. Hologic Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 73. Hologic Tuberculosis (TB) Diagnostics Product Offered
Table 74. Hologic Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Hologic Main Business
Table 76. Hologic Latest Developments
Table 77. Qiagen Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 78. Qiagen Tuberculosis (TB) Diagnostics Product Offered
Table 79. Qiagen Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Qiagen Main Business
Table 81. Qiagen Latest Developments
Table 82. BioMerieux Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 83. BioMerieux Tuberculosis (TB) Diagnostics Product Offered
Table 84. BioMerieux Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. BioMerieux Main Business
Table 86. BioMerieux Latest Developments
Table 87. Hain Lifescience Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 88. Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
Table 89. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Hain Lifescience Main Business
Table 91. Hain Lifescience Latest Developments
Table 92. Oxford Immunotec Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 93. Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
Table 94. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Oxford Immunotec Main Business
Table 96. Oxford Immunotec Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Tuberculosis (TB) Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Tuberculosis (TB) Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Tuberculosis (TB) Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type in 2024
Figure 10. Tuberculosis (TB) Diagnostics in Diagnostic Laboratories
Figure 11. Global Tuberculosis (TB) Diagnostics Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 12. Tuberculosis (TB) Diagnostics in Hospitals
Figure 13. Global Tuberculosis (TB) Diagnostics Market: Hospitals (2020-2025) & ($ millions)
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application in 2024
Figure 15. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player in 2024
Figure 16. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 17. Americas Tuberculosis (TB) Diagnostics Market Size 2020-2025 ($ millions)
Figure 18. APAC Tuberculosis (TB) Diagnostics Market Size 2020-2025 ($ millions)
Figure 19. Europe Tuberculosis (TB) Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Americas Tuberculosis (TB) Diagnostics Value Market Share by Country in 2024
Figure 22. United States Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Region in 2024
Figure 27. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 28. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 29. China Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. India Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Country in 2024
Figure 36. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 37. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 38. Germany Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. France Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Tuberculosis (TB) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 52. APAC Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 53. Europe Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. United States Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Canada Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. Mexico Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Brazil Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. China Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Japan Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. Korea Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. India Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Australia Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Germany Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. France Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. UK Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Italy Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Russia Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Egypt Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. South Africa Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Israel Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Turkey Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Tuberculosis (TB) Diagnostics Market Size 2026-2031 ($ millions)